|
Dr.
Richard D. Weisel
The effects of ischemic preconditioning on cardiac
viability, metabolism, signal transduction and
second messenger activation in a cell culture
model employing human cardiomyocytes endothelial
cells and fibroblasts (Cardiovascular Research,
1994;28:1285-1291). We recently evaluated oxyradical
- induced antioxidant lipid changes in human cardiomyocytes
(American Journal of Physiology, 1994;26, Heart
Circulation Physiology 35;H2204-H2211). We identified
the oxygen responsive element of the human glutathione
peroxidase gene (Journal of Biologic Chemistry,
1993;36:26904-26910).
We investigated the effects of
ischemic preconditioning on cardiac viability,
metabolism, signal transduction and second messenger
activation in a cell culture model employing human
cardiomyocytes endothelial cells and fibroblasts
(Cardiovascular Research, 1994;28:1285-1291).
We recently evaluated oxyradical - induced antioxidant
lipid changes in human cardiomyocytes (American
Journal of Physiology, 1994;26, Heart Circulation
Physiology 35;H2204-H2211). We identified the
oxygen responsive element of the human glutathione
peroxidase gene (Journal of Biologic Chemistry,
1993;36:26904-26910).
We evaluated the protective
effects of vitamin E for coronary bypass
surgery in a prospective, double-blind randomized
trial (Journal of Thoracic and Cardiovascular
Surgery, 1994;108:302-310). We carefully
evaluated ventricular function employing
a nuclear ventriculography and intraventricular
pressure measurements in patients who received
either warm or cold heart surgery (Journal
of Thoracic and Cardiovascular Surgery,
1993; 105:833-844). We compared alternate
techniques of myocardial protection on the
recovery of heart function and metabolism
( Annals of Thoracic Surgery, 1993;56:1020-1028,
Journal of Thoracic and Cardovascular Surgery,
1994; 107:510-519, Annals of Thoracic Surgery,
1994;58:961-971).
The ischemic and reperfusion group
of the Centre for Cardiovascular Research has
an interest in molecular biology, cell signalling
and large animal studies to determine the best
methods of protecting the heart from ischemic
and reperfusion injury during cardiac surgery.
We have performed a series of clinical trails
of evaluating techniques and additives for cardioplegic
protection. We evaluate outcomes at The Toronto
Hospital and with the Institute for Evaluative
Sciences at Sunnybrook. We span the spectrum of
research from the bench to the bedside.
Dr.
Carin Wittnich
Understanding and preventing damage to the hearts
of infants undergoing heart surgery as well as
those hearts with advanced pathology such as hypertrophy
and failure. Functional and metabolic approaches
are used to study these conditions and identify
specific limitations amenable to intervention
which would favourably ameliorate the surgical
outcome and minimize risk. Present professional
activities include running the Cardiovascular
Sciences Collaborative Program (graduate program)
at the university; Staff, Division of Cardiovascular
Surgery, The Hospital for Sick Children and consultant
to their Research Institute; member, Centre for
Cardiovascular Research. Future interests are
in the molecular and cellular biology of the developing
myocardium and the long term effects of cyanosis.
|